Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA7 | P43166 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | TACR1 | P25103 | 4/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13595470 | 1.00 | CA1 (0.54) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL13595479 | 1.00 | CA1 (0.54) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL13108196 | 1.00 | CA1 (0.54) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL10587310 | 1.00 | CA1 (0.54) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL2420068 | 0.96 | CA1 (0.54) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL7450610 | 0.96 | CA1 (0.54) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL27391960 | 0.96 | CA1 (0.54) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL10438673 | 0.95 | CA1 (0.53) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL9818862 | 0.95 | CA1 (0.53) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL9818869 | 0.95 | CA1 (0.53) | CA1CA2CA7CA9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4083107-B1 | METHOD FOR PURIFYING BRANCHED POLYETHYLENE GLYCOL | NOF CORP (JP) | 2025-11-12 | — | — | EP | disclosed |
| US-12378356-B2 | Method for purifying branched polyethylene glycol | NOF CORPORATION (JP) | 2025-08-05 | — | — | US | disclosed |
| US-20220363824-A1 | METHOD FOR PURIFYING BRANCHED POLYETHYLENE GLYCOL | NOF CORPORATION (JP) | 2022-11-17 | — | — | US | disclosed |
| EP-4083107-A1 | METHOD FOR PURIFYING BRANCHED POLYETHYLENE GLYCOL | NOF Corporation (JP) | 2022-11-02 | — | — | EP | disclosed |
| CN-114929781-A | Process for purifying branched polyethylene glycols | 日油株式会社 | 2022-08-19 | — | — | CN | disclosed |
| WO-2021132123-A1 | METHOD FOR PURIFYING BRANCHED POLYETHYLENE GLYCOL | 日油株式会社 | 2021-07-01 | — | — | WO | disclosed |
| US-8716435-B2 | Multibranched polyoxyalkylene compound and producing method thereof | NOF CORPORATION (JP) | 2014-05-06 | — | — | US | disclosed |
| EP-2415800-B1 | HYPERBRANCHED POLYOXYALKYLENE COMPOUND AND METHOD FOR PRODUCING SAME | NOF CORP (JP) | 2013-10-16 | — | — | EP | disclosed |
| EP-2415800-A1 | HYPERBRANCHED POLYOXYALKYLENE COMPOUND AND METHOD FOR PRODUCING SAME | NOF Corporation (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20100261863-A1 | MULTIBRANCHED POLYOXYALKYLENE COMPOUND AND PRODUCING METHOD THEREOF | NOF CORPORATION (JP) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261863-A1 | MULTIBRANCHED POLYOXYALKYLENE COMPOUND AND PRODUCING METHOD THEREOF | OPRM1, AOC2, OPRK1 | CA1 798/4885CA2 2194/4885CA7 1953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.